OK Biotech Co., Ltd. (TPE:4155)
Taiwan
· Delayed Price · Currency is TWD 13.90
+0.15 (1.09%)
Mar 10, 2026, 11:00 AM CST
OK Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,944 | 3,007 | 3,656 | 2,643 | 2,217 | 2,524 | Upgrade
|
| Market Cap Growth | -36.45% | -17.75% | 38.36% | 19.21% | -12.17% | 2.03% | Upgrade
|
| Enterprise Value | 2,776 | 3,384 | 3,420 | 2,738 | 2,319 | 2,476 | Upgrade
|
| Last Close Price | 13.75 | 20.09 | 24.35 | 22.82 | 18.51 | 20.22 | Upgrade
|
| PE Ratio | 29.11 | 32.00 | 1240.26 | 18.42 | 51.00 | 19.45 | Upgrade
|
| PS Ratio | 1.19 | 1.80 | 3.07 | 1.78 | 1.76 | 1.70 | Upgrade
|
| PB Ratio | 0.77 | 1.17 | 1.53 | 1.43 | 1.30 | 1.45 | Upgrade
|
| P/TBV Ratio | 0.98 | 1.49 | 1.54 | 1.46 | 1.34 | 1.51 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 37.16 | Upgrade
|
| P/OCF Ratio | 20.39 | 45.63 | 1246.60 | 10.99 | 101.24 | 17.03 | Upgrade
|
| EV/Sales Ratio | 1.69 | 2.03 | 2.87 | 1.85 | 1.84 | 1.67 | Upgrade
|
| EV/EBITDA Ratio | 15.96 | 27.02 | 56.71 | 16.50 | 38.83 | 14.46 | Upgrade
|
| EV/EBIT Ratio | 31.72 | 59.15 | - | 26.89 | 286.69 | 19.63 | Upgrade
|
| EV/FCF Ratio | -9.16 | - | - | - | - | 36.46 | Upgrade
|
| Debt / Equity Ratio | 0.43 | 0.28 | 0.14 | 0.42 | 0.43 | 0.18 | Upgrade
|
| Debt / EBITDA Ratio | 6.29 | 5.57 | 5.23 | 4.60 | 11.49 | 1.79 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 4.63 | Upgrade
|
| Net Debt / Equity Ratio | 0.31 | 0.17 | -0.01 | 0.08 | 0.05 | -0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.66 | 3.43 | -0.55 | 0.87 | 1.49 | -1.47 | Upgrade
|
| Net Debt / FCF Ratio | -2.54 | -1.38 | 0.08 | -3.11 | -1.56 | -3.72 | Upgrade
|
| Asset Turnover | 0.45 | 0.49 | 0.39 | 0.51 | 0.47 | 0.63 | Upgrade
|
| Inventory Turnover | 2.62 | 3.02 | 2.44 | 2.85 | 2.97 | 3.24 | Upgrade
|
| Quick Ratio | 1.09 | 1.18 | 1.48 | 1.26 | 1.50 | 1.34 | Upgrade
|
| Current Ratio | 1.79 | 1.98 | 2.28 | 1.84 | 2.13 | 1.95 | Upgrade
|
| Return on Equity (ROE) | 3.36% | 4.29% | -0.07% | 7.70% | 1.83% | 7.98% | Upgrade
|
| Return on Assets (ROA) | 1.47% | 1.06% | -0.25% | 2.17% | 0.19% | 3.32% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.43% | 1.79% | 0.11% | 4.19% | 0.34% | 6.72% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.80% | 1.90% | -0.50% | 4.60% | 0.40% | 6.70% | Upgrade
|
| Earnings Yield | 3.54% | 3.13% | 0.08% | 5.43% | 1.96% | 5.14% | Upgrade
|
| FCF Yield | -15.58% | -10.33% | -11.67% | -1.75% | -2.58% | 2.69% | Upgrade
|
| Dividend Yield | 2.14% | 1.49% | 1.23% | 4.89% | 4.90% | 6.28% | Upgrade
|
| Payout Ratio | 127.85% | 46.95% | 4906.38% | 66.17% | 303.37% | 86.44% | Upgrade
|
| Buyback Yield / Dilution | -8.28% | -14.02% | 1.41% | -9.95% | -18.84% | -16.16% | Upgrade
|
| Total Shareholder Return | -6.14% | -12.53% | 2.64% | -5.06% | -13.94% | -9.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.